Save time and money with
Med Tech Market Research

MedTech Business intelligence
supplied by GlobalData

Alzheimer's drugs


For more information: description, contents, tables, figures
click on a title below

Aricept (Alzheimer’s Disease) - Forecast and Market Analysis to 2022

Exelon (Alzheimer’s Disease) - Forecast and Market Analysis to 2022

Razadyne/Reminyl (Alzheimer’s Disease) - Forecast and Market Analysis to 2022

Namenda (Alzheimer’s Disease) - Forecast and Market Analysis to 2022

Arimenda (Alzheimer’s Disease) - Forecast and Market Analysis to 2022

Solanezumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022

Crenezumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022

TRx0237 (Alzheimer’s Disease) - Forecast and Market Analysis to 2022

MK-8931(Alzheimer’s Disease) - Forecast and Market Analysis to 2022

EVP-6124 (Alzheimer’s Disease) - Forecast and Market Analysis to 2022

Lu AE58054 (Alzheimer’s Disease) - Forecast and Market Analysis to 2022

PharmaPoint: Alzheimer’s Disease - Current and Future Players

 
 
 
 
 
 
 
 
 
 

 

 

To top

 

 

To top